Trial intelligence / Profile preview

Chloroquine as Chemoprophylaxis Versus Intermittent Preventive Therapy to Prevent Malaria in Pregnancy in Malawi

NCT01443130Phase 3Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Start
Feb 2012
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of chloroquine in malaria, sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2012; status: completed.

02

Drugs

chloroquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01443130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01443130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call